6 completed, 5 unknown, 2 active not recruiting, 2 recruiting. 7 Not applicable, 2 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.
Follow Unilateral Breast Neoplasms: new trials by email Literature Review of Unilateral Breast Neoplasms trials Research Report on Unilateral Breast Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk XAINET AI tool - Unilateral Breast Neoplasms | Not applicable | Recruiting | UNICANCER | 724 | 2025-10-07 | 2026-05-19 |
| A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. PF-07248144, Fulvestrant, Everolimus - Breast Cancer | Phase 3 | Recruiting | Pfizer | 400 | 2025-08-05 | 2026-10-19 |
| Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease PF-07220060, letrozole, abemaciclib - Breast Cancer | Phase 3 | Active not recruiting | Pfizer | 1035 | 2025-01-06 | 2026-10-16 |
| 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy Respiratory gating - Breast Cancer, Radiation-Induced Vascular Disease | Not applicable | Unknown | Central Hospital Saint Quentin | 15 | 2023-03-02 | 2023-06-09 |
| A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose Continuous Positive Airway Pressure, Deep inspiratory breath hold, Free Breath - Lung Cancer, Left Sided Breast Cancer | Not applicable | Completed | Case Comprehensive Cancer Center | 8 | 2022-10-19 | 2026-02-02 |
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer Abemaciclib, Niraparib Tosylate Monohydrate - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Completed | OHSU Knight Cancer Institute | 8 | 2021-06-07 | 2026-01-29 |
| Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity [1-13C]pyruvate along with MRI imaging - Thoracic Cancer, Left Sided Breast Cancer | Early Phase 1 | Terminated | University of Texas Southwestern Medical Center | 3 | 2019-12-17 | 2026-02-02 |
| Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer Radiotherapy Confirmed Left-Sided Breast Cancer - Left-Sided Breast Cancer, Radiation Toxicity | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 15 | 2019-01-01 | 2018-11-27 | |
| Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control AlignRT system (VisionRT Ltd., London, UK) - Left-Sided Breast Cancer | Not applicable | Completed | Sunnybrook Health Sciences Centre | 40 | 2018-05-19 | 2022-05-05 |
| Prevalence of Lymphedema in Valle Del Cauca, Colombia. Development and validation of Lymphedema levels diagnostic - Unilateral Breast Cancer | Unknown | Grupo de investigación C.E.R | 367 | 2018-01-18 | 2021-08-09 | |
| MIAMI Safe Surgery for Multiple Breast Cancers Mastectomy, Therapeutic Mammoplasty - Breast Cancer, Unilateral | Not applicable | Completed | University College, London | 4 | 2017-11-01 | 2021-05-18 |
| Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Cyclophosphamide, Laboratory Biomarker Analysis, Multi-epitope Folate Receptor Alpha Peptide Vaccine - Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma | Phase 2 | Active not recruiting | Academic and Community Cancer Research United | 280 | 2017-03-31 | 2026-06-30 |
| Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing PERSBRA - Breast Neoplasms, Breast Cancer | Not applicable | Unknown | Taipei Medical University Hospital | 50 | 2016-04-21 | 2022-11-08 |
| Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart Radiation therapy - Breast Cancer, Adverse Effect of Radiation Therapy | Phase 2 | Unknown | AHS Cancer Control Alberta | 63 | 2014-10-01 | 2017-01-06 |
| Cosmetic and Functional Outcomes After Breast Conserving Surgery Lumpectomy, axillary block dissection, breast conserving surgery, Radiotherapy - Breast Cancer | Not applicable | Completed | National Institute of Oncology, Hungary | 300 | 2011-03-01 | 2015-10-06 |
| Ethnic Predisposition, Risk Factors & Breast Cancer Presentation. Breast Cancer positive patients - Breast Cancer | Completed | Bahria University | 500 | 2010-01-01 | 2022-07-14 |
Breast Neoplasms (10) · Radiation Injuries (3) · Cardiotoxicity (2) · Recurrence (2) · Breast Cancer, Familial (1) · Coronary Artery Disease (1) · Coronary Stenosis (1) · Inflammatory Breast Neoplasms (1) · Leukocyte adhesion deficiency type 1 (1) · Lung Neoplasms (1) · Lymphedema (1) · Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (16) · Neoplasms by Site (16) · Skin Diseases (16) · Skin and Connective Tissue Diseases (16) · Neoplasms (15) · Breast Neoplasms (6) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Wounds and Injuries (4) · Cardiovascular Diseases (3) · Heart Diseases (3) · Chemically-Induced Disorders (2) · Disease Attributes (2) · Drug-Related Side Effects and Adverse Reactions (2) · Arterial Occlusive Diseases (1)
Radiotherapy (2) · abemaciclib (2) · Colony-Stimulating Factors (1) · Continuous Positive Airway Pressure (1) · Cyclophosphamide (1) · Everolimus (1) · Fulvestrant (1) · Growth and Development (1) · Letrozole (1) · Mastectomy (1) · Mastectomy, Segmental (1) · exemestane (1) · niraparib (1) · palbociclib (1) · ribociclib (1)
Pfizer (2) · AHS Cancer Control Alberta (1) · Academic and Community Cancer Research United (1) · Bahria University (1) · Case Comprehensive Cancer Center (1) · Central Hospital Saint Quentin (1) · Grupo de investigación C.E.R (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · National Institute of Oncology, Hungary (1) · OHSU Knight Cancer Institute (1) · Sunnybrook Health Sciences Centre (1) · Taipei Medical University Hospital (1) · UNICANCER (1) · University College, London (1) · University of Texas Southwestern Medical Center (1)
United States (6) · Canada (5) · France (4) · Hungary (3) · Netherlands (3) · Taiwan (3) · United Kingdom (3) · Argentina (2) · Australia (2) · Belgium (2) · Brazil (2) · Bulgaria (2) · China (2) · Czechia (2) · Finland (2)
Alexandra Zimmer, M.D. (1) · Jeng-Feng Chiou, MD, Ph.D. (1) · Kathryn J Ruddy (1) · Kurian Joseph, MB, FFRRCSI, FRCR, FRCPC (1) · Long-Sheng Lu, MD, Ph.D. (1) · Prasanna Alluri, MD, PhD (1) · Sheeh Cherian, MD (1) · Stewart Gaede, PhD (1) · Zoe Winters (1)
2025 (1), P30CA015083 (1)